Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03)

Funding Opportunity Announcement (FOA) Number	PAR-13-344
Companion Funding Opportunity	PAR-13-325, R01 Research Project Grant PAR-13-326, R21 Exploratory/Developmental Research Grant Award
Number of Applications	See Section III. 3. Additional Information on Eligibility.
Catalog of Federal Domestic Assistance (CFDA) Number(s)	93.865
Funding Opportunity Purpose	The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development, testing and use of newly developed techniques superior to the ones currently used in the field.

Key Dates

Posted Date	September 4, 2013
Open Date (Earliest Submission Date)	September 16, 2013
Letter of Intent Due Date(s)	30 days prior to the application due date
Application Due Date(s)	Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.